Your browser doesn't support javascript.
loading
Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response.
Liu, Ning Qing; De Marchi, Tommaso; Timmermans, Annemieke M; Beekhof, Robin; Trapman-Jansen, Anita M A C; Foekens, Renée; Look, Maxime P; van Deurzen, Carolien H M; Span, Paul N; Sweep, Fred C G J; Brask, Julie Benedicte; Timmermans-Wielenga, Vera; Debets, Reno; Martens, John W M; Foekens, John A; Umar, Arzu.
Affiliation
  • Liu NQ; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute, ‡‡Netherlands Proteomics Centre, Utrecht, The Netherlands; §§Postgraduate School of Molecular Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands; ¶¶Department of Molecular Biology, Faculty of Science, Nijmege
  • De Marchi T; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute, §§Postgraduate School of Molecular Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands;
  • Timmermans AM; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute.
  • Beekhof R; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute.
  • Trapman-Jansen AM; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute.
  • Foekens R; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute.
  • Look MP; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute.
  • van Deurzen CH; §Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands;
  • Span PN; ¶Department of Radiation Oncology.
  • Sweep FC; ‖Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands;
  • Brask JB; **Department of Pathology, the Centre of Diagnostic Investigations, Copenhagen University Hospital, Copenhagen, Denmark;
  • Timmermans-Wielenga V; **Department of Pathology, the Centre of Diagnostic Investigations, Copenhagen University Hospital, Copenhagen, Denmark;
  • Debets R; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute.
  • Martens JW; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute, ‡‡Netherlands Proteomics Centre, Utrecht, The Netherlands;
  • Foekens JA; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute, ‡‡Netherlands Proteomics Centre, Utrecht, The Netherlands;
  • Umar A; From the ‡Department of Medical Oncology, Erasmus MC Cancer Institute, ‡‡Netherlands Proteomics Centre, Utrecht, The Netherlands; a.umar@erasmusmc.nl.
Mol Cell Proteomics ; 13(7): 1814-27, 2014 Jul.
Article in En | MEDLINE | ID: mdl-24742827
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Apoferritins / Biomarkers, Tumor / CD8-Positive T-Lymphocytes / Ferritins / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2014 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Apoferritins / Biomarkers, Tumor / CD8-Positive T-Lymphocytes / Ferritins / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2014 Type: Article